Can Calcium, Phosphate, Calcium Phosphate Product and Intact Parathyroid Hormone Levels Be Appropriately Controlled in Dialysis Patients? | Zendy

Serpil Müge Değer | Zendy; Rüya Mutluay | Zendy; Ülver Derici | Zendy; F. Mandiralioglu | Zendy; Tekin Arinsoy | Zendy; Şükrü Sindel | Zendy

Open Access

Can Calcium, Phosphate, Calcium Phosphate Product and Intact Parathyroid Hormone Levels Be Appropriately Controlled in Dialysis Patients?

Author(s) -

Serpil Müge Değer,

Rüya Mutluay,

Ülver Derici,

F. Mandiralioglu,

Tekin Arinsoy,

Şükrü Sindel

Publication year - 2010

Publication title -

medical principles and practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.426

H-Index - 45

eISSN - 1423-0151

pISSN - 1011-7571

DOI - 10.1159/000319768

Subject(s) - medicine , parathyroidectomy , parathyroid hormone , peritoneal dialysis , calcium , dialysis , urology , hemodialysis , kidney disease , vitamin d and neurology , phosphate binder , phosphate , nephrology , endocrinology , secondary hyperparathyroidism , gastroenterology , hyperphosphatemia , biochemistry , chemistry

To review the target levels of calcium (Ca), phosphate (P), calcium phosphate products (Ca × P) and intact parathyroid hormone (iPTH) levels in patients undergoing hemodialysis (HD) and peritoneal dialysis (PD) and compare them with the Kidney Disease Outcome Quality Initiative (K/DOQI) recommendations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research